West Pharmaceutical Services, Inc. (WST) looks overvalued — trading about 54% above its fair value.
OvervaluedSee the full interactive analysis →
Fair value compares WST's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.